Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

Comparative Effectiveness of Management Strategies for Adults With Gastroesophageal Reflux Disease: An Update

Slide: 22 of 26

Findings of the Comparative Effectiveness Review: Endoscopic Treatments (1 of 2)

Recently, endoscopic treatments have been proposed to reduce the need for long-term use of acid-reducing medications in patients with GERD. The original 2005 review on GERD treatments evaluated studies on four endoscopic procedures: the EndoCinch™ Suturing System, Stretta®, Enteryx™, and the NDO Plicator™. The present updated report excluded Enteryx and the NDO Plicator because they are no longer available in the United States. Stretta was removed from the market but reintroduced in 2010 by a separate manufacturer. Another device, EsophyX™, was commercialized after the original review. Evidence of low strength yielded mixed results regarding the effectiveness of the endoscopic treatment EndoCinch for improving symptoms, quality of life, and healing of esophagitis.

No studies directly comparing endoscopic treatments were identified for this update; however, a number of sham-controlled and cohort studies examining the effectiveness of the individual procedures were reviewed.

Abbreviation:
GERD = gastroesophageal reflux disease